Skip to main content

Table 1 Clinical characteristic of studied subjects with and without ASCVD

From: Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease

 

Total

Non-ASCVD

ASCVD

P value

Number (%)

425

360 (84.71)

65 (15.29)

 

Age (years)

58.72 ± 6.82

58.27 ± 6.68

61.21 ± 7.12

0.001

Female (%)

260 (61.2)

212 (58.9)

48 (73.8)

0.023

Smoking, n (%)

112 (26.4)

101 (28.1)

11 (16.9)

0.061

Alcohol, n (%)

125 (29.4)

114 (31.7)

11 (16.9)

0.016

High educational level, n (%)

26 (6.1)

22 (6.1)

4 (6.2)

0.989

Physical activity, n (%)

332 (78.1)

281 (78.1)

51 (78.5)

0.942

Family history of ASCVD, n (%)

187 (44.0)

150 (41.7)

37 (56.9)

0.023

Central obesity, n (%)

311 (73.2)

257 (71.4)

54 (83.1)

0.050

General obesity

   

0.890

 Overweight, n (%)

191 (44.9)

162 (45.0)

29 (44.6)

 

 Obesity, n (%)

132 (31.1)

113 (31.4)

19 (29.2)

 

Duration of DM (years)

10.39 ± 3.24

10.34 ± 3.16

10.69 ± 3.70

0.416

FPG (mmol/l)

8.61 ± 2.64

8.50 ± 2.58

9.22 ± 2.95

0.042

HbA1c (%)

7.36 ± 1.75

7.25 ± 1.68

7.94 ± 2.04

0.004

Hypertension, n (%)

328 (77.2)

275 (76.4)

53 (81.5)

0.363

SBP (mmHg)

150.56 ± 20.17

150.30 ± 20.20

152.06 ± 20.11

0.518

DBP (mmHg)

87.16 ± 11.19

87.37 ± 11.25

85.98 ± 10.86

0.360

TC (mmol/l)

5.37 ± 1.14

5.37 ± 1.13

5.37 ± 1.19

0.977

TG (mmol/l)

2.31 ± 1.96

2.33 ± 2.05

2.19 ± 1.36

0.588

LDL-C (mmol/l)

2.71 ± 0.54

2.71 ± 0.53

2.73 ± 0.59

0.802

HDL-C (mmol/l)

1.45 ± 0.29

1.45 ± 0.29

1.47 ± 0.32

0.589

eGFR (ml/min/1.73 m2)

92.42 ± 17.68

93.31 ± 17.73

87.53 ± 16.69

0.015

  1. Data are means ± SE or raw numbers (%). Continuous data were used for univariate general linear models and categorical data were analyzed by χ2 tests.